Skip to main content
. 2020 Aug 31;10:14326. doi: 10.1038/s41598-020-71161-0

Table 1.

Extracted cfDNA amount and detected genetic alterations.

ID Tumor/control Clinical diagnosis CSF volume for ctDNA extraction (ml) cfDNA concentration (ng/μL) Input cfDNA (ng) Genetic alterations AF%
06 Control CMV 1.28 17.5 20.00 ND
13 Control NPH 2.88 0.876 9.11 ND
08 Tumor Germinoma 2.88 0.684 7.11 ND
20 Tumor Recurrent germinoma 1.78 0.556 5.78 MAP2K1 p.F129L 1.6
21 Tumor Mature teratoma 2.28 45.2 20.00 ND
02 Tumor Germinoma 2.88 2.52 20.00 ND
04 Tumor Yolk-sac tumor 1.38 0.302 3.14 NRAS p.Q61R 34.6
05 Tumor Germinoma 1.38 0.266 2.77 ND
10 Tumor Germinoma 1.38 0.466 4.85 KIT p.D820G 18.7
12 Tumor GERMINOMA 0.88 0.264 2.75 ND
15 Tumor Germinoma 1.38 0.536 5.57 NRAS p.G12S 40.3
KIT p.N822Y 32.3
16 Tumor Germinoma 1.38 0.216 2.25 ND
17 Tumor Immature teratoma 1.38 0.342 3.56 ND
19 Tumor Germinoma 0.38 0.518 5.39 ND

CMV cytomegalovirus infection, NPH normal pressure hydrocephalus, AF allele frequency, ND not detected.